Thursday, February 5, 2015

A Deal That Could Reverse Pfizer’s History of Value-Destroying Acquisitions by ROBERT CYRAN



By ROBERT CYRAN


The pharmaceutical giant’s $15 billion purchase of Hospira should bolster Pfizer’s own generics unit – and open the way for spinning it off, says Robert Cyran of Reuters Breakingviews.


Published: February 5, 2015 at 09:10AM


from NYT Business Day http://ift.tt/1DJPLSI








from WordPress http://ift.tt/16vPNm5
Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)